title: Splenomegaly and hepatomegaly at onset of blastic crisis in chronic myeloid leukaemia have prognostic importance.
authors.forename: P M
authors.initials: PM
authors.lastname: Parikh
authors.forename: B S
authors.initials: BS
authors.lastname: Charak
authors.forename: S D
authors.initials: SD
authors.lastname: Banavali
authors.forename: S B
authors.initials: SB
authors.lastname: Koppikar
authors.forename: N K
authors.initials: NK
authors.lastname: Giri
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: T K
authors.initials: TK
authors.lastname: Saikia
authors.forename: R
authors.initials: R
authors.lastname: Gopal
authors.forename: A T
authors.initials: AT
authors.lastname: Mazumdar
authors.forename: S H
authors.initials: SH
authors.lastname: Advani
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001752:Blast Crisis / Q000188:drug therapy*; D002648:Child; D005260:Female; D006529:Hepatomegaly; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013163:Splenomegaly